The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Predictors of New-Onset Kidney Disease in a Community-Based Population
Abstract
Context Kidney disease is associated with an increased risk for the development of cardiovascular disease and end-stage renal disease; however, risk factors for kidney disease have not been well studied. Objective To identify predictors of the development of new-onset kidney disease. Design, setting, and participants A community-based, longitudinal cohort study of 2585 participants who attended both a baseline examination in 1978-1982 and a follow-up examination in 1998-2001, and who were free of kidney disease at baseline. Main outcome measures Kidney disease was assessed by the Modification of Diet in Renal Disease Study equation and defined by a glomerular filtration rate (GFR) in the fifth or lower percentile ( Results At baseline, there were 1223 men and 1362 women, with a mean age of 43 years, who were free of preexisting kidney disease. After a mean follow-up of 18.5 years, 244 participants (9.4%) had developed kidney disease. In multivariable models, baseline age (odds ratio [OR], 2.36 per 10-year increment; 95% confidence interval [CI], 2.00-2.78), GFR ( or =120 mL/min per 1.73 m2), a mildly reduced GFR ( Conclusions Established cardiovascular disease risk factors are associated with the development of new-onset kidney disease. Patients with a mildly reduced GFR should be monitored for progression to kidney disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While dyslipidemia is a risk factor for progressive kidney disease (8,10,20,21)”
From Effects of Fibrates in Kidney Disease (2012) · cites this paper as [8]
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,003
Chronic kidney disease: stemming the global tide.
Nwankwo, E., Bello, A., & el Nahas, A. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.005 · Cited by 36
Qin, Z., Chen, X., Sun, J., & Jiang, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1076301 · Cited by 52
Weldegiorgis, M., & Woodward, M. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02932-2 · Cited by 40
“In a community-based, longitudinal cohort study of 2585 individuals, the HDL-C level predicted the development of new-onset kidney disease [24].”
BackgroundObesity and Long-Term Mortality Risk among Living Kidney Donors
Locke, J., Reed, R., Massie, A., MacLennan, P., Sawinski, D., Kumar, V., Snyder, J., Carter, A. J., Shelton, B. A., Mustian, M. N., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.03.016 · Cited by 35
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial
Scirica, B. M., Bohula, E. A., Dwyer, J. P., Qamar, A., Inzucchi, S. E., McGuire, D. K., KEECH, A. C., Smith, S. R., Murphy, S. A., Im, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038341 · Cited by 35
Metabolically Healthy Obesity and Risk of Kidney Function Decline
Chang, A. R., Surapaneni, A., Kirchner, H., Young, A., Kramer, H., Carey, D., Appel, L. J., & Grams, M. E. (2018) · Obesity · doi:10.1002/oby.22134 · Cited by 35
Association between Renal Function and Open-Angle Glaucoma
Shim, S. H., Sung, K., Kim, J. M., Lee, M. Y., Won, Y. S., Kim, J. H., & Park, K. H. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.06.022 · Cited by 38
Funk, J., Ott, V., Herrmann, A., Rapp, W., Raab, S., Riboulet, W., Vandjour, A., Hainaut, E., Bénardeau, A., Singer, T., et al. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1391-6 · Cited by 35
Sarafidis, P. A., Georgianos, P. I., & Zebekakis, P. E. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.08.001 · Cited by 38
Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin
Cappelletty, D., Jabłoński, A., & Jung, R. (2014) · Clinical drug investigation · doi:10.1007/s40261-013-0163-0 · Cited by 35
Olden, M., Teumer, A., Bochud, M., Pattaro, C., Köttgen, A., Turner, S., Rettig, R., Chen, M.-H., Dehghan, A., Bastardot, F., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.12.024 · Cited by 35
Self-citationNistala, R., & Whaley‐Connell, A. T. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.005 · Cited by 38
Nonprogressive Kidney Dysfunction and Outcomes in Older Adults with Chronic Kidney Disease
El-Ghoul, B., Elie, C., Sqalli, T., Jungers, P., Daudon, M., Grünfeld, J., Lesavre, P., & Joly, D. (2009) · Journal of The American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02561.x · Cited by 35
OBESITY INDUCED RENAL OXIDATIVE STRESS CONTRIBUTES TO RENAL INJURY IN SALT-SENSITIVE HYPERTENSION
Quigley, J. E., Elmarakby, A. A., Knight, S., Manhiani, M., Stepp, D., Olearzcyk, J. J., & Imig, J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05139.x · Cited by 35
“Each of these components are independent risk factors for chronic kidney disease and progression to end-stage renal disease (ESRD).(4,5) Prevention and medical treatment of hypertension as a component of metabolic syndrome will reduce mortality and health care costs.”
BackgroundShin, J., Sang, Y., Chang, A. R., Dunning, S. C., Coresh, J., Inker, L. A., Selvin, E., Ballew, S. H., & Grams, M. E. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019101119 · Cited by 39
“, baseline comparison periods: [1] August 7, 2012 to May 1, 2013; [2] May 2, 2013 to January 24, 2014; [3] January 25, 2014 to October 19, 2014; and [4] October 20, 2014 to July 14, 2015) to compare with the 9-month period prevalent cohort after the label change, and then, we assessed racial and sex differences in met…”
MethodKim, Y.-H., Kang, J., Lee, S.-J., Han, K., Ihm, S., Cho, K.-H., & Park, Y. (2020) · Diabetes Care · doi:10.2337/dc19-2095 · Cited by 34
Semu, H., Zack, R., Liu, E., Hertzmark, E., Spiegelman, D., Sztam, K. A., Hawkins, C., Chalamila, G., Muya, A., Siril, H., et al. (2014) · Journal of the International Association of Providers of AIDS Care · doi:10.1177/2325957414542574 · Cited by 34
Dittmann, K., Hannemann, A., Wallaschofski, H., Rettig, R., Stracke, S., Völzke, H., Nauck, M., & Friedrich, N. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-87 · Cited by 34
“Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS: Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.”
BackgroundMethodInfluentialDrechsler, C., de Mutsert, R., Grootendorst, D., Boeschoten, E., Krediet, R., le Cessie, S., Wanner, C., & Dekker, F. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.027 · Cited by 34
Sumaili, E., Nseka, N., Lepira, F., Krzesinski, J., Makulo, J., Bukabau, J., Nkoy, J., Mokoli, V., Longokolo, M., Owandjalola, J. A., et al. (2008) · Nephron Clinical Practice · doi:10.1159/000167869 · Cited by 34
“Therefore, determination of risk factors for the development of proteinuria might facilitate focused preventive and therapeutic tools to delay the progression of CKD. Previous studies have suggested that markers for cardiovascular disease are also risk factors for renal disease and proteinuria [”
BackgroundZhao, J. Z., Weinhandl, E. D., Carlson, A. M., & St. Peter, W. L. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2022.100564 · Cited by 33
“Diabetes has long been known to be associated with the development of cardiovascular and kidney disease.(3,4)”
BackgroundChanges in obese metabolic phenotypes over time and risk of incident chronic kidney disease
Nam, K., Yun, H., Joo, Y. S., Kim, J., Lee, S.-M., Lee, C., Park, K. S., Park, J., Chang, T., Kang, E., et al. (2018) · Diabetes, obesity and metabolism · doi:10.1111/dom.13458 · Cited by 33
Smoking and Chronic Kidney Disease in Healthy Populations
Noborisaka, Y. (2012) · Nephro-Urology Monthly · doi:10.5812/numonthly.3527 · Cited by 33
“Sixteen of the 28 articles reported the effects of smoking on proteinuria or albuminuria (7, 1226), and 21 reported the effects on renal function (7, 12, 14, 15, 17, 21, 22, 25-38).”
BackgroundResultImpact of metabolic syndrome on the incidence of chronic kidney disease: A Chinese cohort study
Yang, T., Chu, C., Hsu, C.-H., Hsieh, P., Chung, T.-C., Bai, C.-H., You, S., Hwang, L.-C., Lin, C.-M., & Sun, C.-A. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01607.x · Cited by 33
“demonstrated that established cardiovascular risk factors are associated with the risk of developing CKD.(9) Accordingly, MetS may be a common phenotype that increases the risk for CKD.”
BackgroundAn association between metabolic syndrome and the estimated glomerular filtration rate.
Kawamoto, R., Kohára, K., Tabara, Y., & Miki, T. (2008) · Internal medicine · doi:10.2169/internalmedicine.47.1202 · Cited by 33
“The subjects comprised 1,158 men aged 61±15 (mean ± standard deviation; range, 20-89) years and 1,606 women aged 63±12 (19-89) years.”
BackgroundCardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Ali, M. M., Parveen, S., Williams, V. R., Dons, R. F., & Uwaifo, G. I. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100341 · Cited by 31
“It is evident that early recognition and detection of ORCKD using various biomarkers by enabling early multi-pronged interventions offers the best prognosis for prevention of CKD progression and the potential for CKD reversal [14,22,34,35,72,76,79,95,96,101,117,120,122,253 – 257].”
BackgroundJo, W., Lee, S.-M., Joo, Y. S., Nam, K., Yun, H., Chang, T., Kang, E., Yoo, T., Han, S., Kang, S.-W., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238111 · Cited by 32
Single-Nephron GFR in Patients With Obesity-Related Glomerulopathy
Okabayashi, Y., Tsuboi, N., Sasaki, T., Haruhara, K., Kanzaki, G., Koike, K., Shimizu, A., D'Agati, V., & Yokoo, T. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.05.013 · Cited by 32
“3 The kidney is 1 of the target organs for obesity-related health disorders, and obesity is an independent risk factor for the development of kidney disease.(4,5) A well-characterized renal complication of obesity is obesity-related glomerulopathy (ORG).”
BackgroundReprint of: Prevention and Control of Hypertension
Carey, R. M., Muntner, P., Bosworth, H. B., & Whelton, P. K. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.022 · Cited by 49
Hruby, A., & Jacques, P. F. (2018) · Public Health Nutrition · doi:10.1017/s1368980018001854 · Cited by 37
“sCr (mmol/l) was assayed using the modified Jaffé colorimetric method (Roche Hitachi 911; Roche Diagnostics, Indianapolis, IN, USA) and calibrated as previously described((30)).”
MethodKuma, A., Uchino, B., Ochiai, Y., Kawashima, M., Enta, K., Tamura, M., Otsuji, Y., & Kato, A. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1407-8 · Cited by 32
“Both decreased HDL-C and elevated TG levels are associated with the risk of incident CKD [3, 24, 25].”
BackgroundSoltani, Z., Washco, V., Morse, S., & Reisin, E. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0520-2 · Cited by 36
Oral health status of patients with a mild decrease in glomerular filtration rate
Garcez, J., Posse, J. L., Tomás, I., Feijoo, J. F., & Dios, P. D. (2009) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2008.09.018 · Cited by 34
Ishizaka, N., Ishizaka, Y., Toda, E., Koike, K., Seki, G., Nagai, R., & Yamakado, M. (2007) · Hypertension Research · doi:10.1291/hypres.30.1059 · Cited by 32
“, BMI was found to be related to the development of kidney disease (16).”
BackgroundProtecting renal function in the hypertensive patient: clinical guidelines.
Bakris, G. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.046 · Cited by 32
“Epidemiologic data show that the development of CKD is associated with diabetes, hypertension, obesity, smoking, and low levels of highdensity lipoprotein cholesterol.(5) Clinical factors that are most predictive for CKD include a family history of renal disease and the presence of diabetes, hypertension, or autoimmun…”
BackgroundFeng, Y.-M., Thijs, L., Zhang, Z.-Y., Yang, W.-Y., Huang, Q.-F., Wei, F.-F., Kuznetsova, T., Jennings, A., Delles, C., Lennox, R., et al. (2017) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfx256 · Cited by 31
“In keeping with recent recommendations [35] and previous studies [24, 36], in our study we applied an early renal endpoint defined as an eGFR<60 mL/min/1.”
BackgroundMethodResultThe impact of malnutritional status on survival in elderly hemodialysis patients
Tsai, M.-T., Liu, H.-C., & Huang, T.-P. (2016) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2016.01.015 · Cited by 31
“hypertension, diabetes mellitus, obesity, and cardiovascular disease, and may contribute to the development and progression of chronic kidney disease.(1,2) Yang and Hwang(3) revealed that the elderly constituted the major proportion of patients with end-stage renal disease (ESRD) in Taiwan.”
BackgroundRisk for chronic kidney disease increases with obesity: Health Survey for England 2010
MacLaughlin, H., Hall, W., Sanders, T., & Macdougall, I. (2015) · Public Health Nutrition · doi:10.1017/s1368980015000488 · Cited by 31
Duzova, A., Yalçınkaya, F., Baskın, E., Bakkaloğlu, A., & Soylemezoglu, O. (2013) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gft317 · Cited by 31
Performance of a Genetic Risk Score for CKD Stage 3 in the General Population
O’Seaghdha, C. M., Yang, Q., Wu, H., Hwang, S., & Fox, C. S. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.08.030 · Cited by 33
“A 2-step calibration process for serum creatinine was used to reduce potential interlaboratory variability.(19) Determinations of serum creatinine were made in a central laboratory, although laboratories used for the original cohort and offspring participants were not the same.”
Self-citationZoccali, C., Kramer, A., & Jager, K. (2009) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.05210709 · Cited by 31
Gómez, P., Ruilope, L., Barrios, V., Navarro, J., Prieto, M., González, O., Guerrero, L., Zamorano, M. A. S., & Filozof, C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080914 · Cited by 31
Rule, A., Jacobsen, S., Schwartz, G. L., Mosley, T., Scott, C., Kardia, S., Boerwinkle, E., & Turner, S. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.10.025 · Cited by 31
Derakhshan, A., Bagherzadeh-Khiabani, F., Arshi, B., Ramezankhani, A., Azizi, F., & Hadaegh, F. (2016) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.116.003917 · Cited by 30
Adiposity patterns and the risk for ESRD in postmenopausal women.
Franceschini, N., Gouskova, N., Reiner, A., Bostom, A., Howard, B., Pettinger, M., Umans, J., Brookhart, M., Winkelmayer, W., Eaton, C., et al. (2015) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.02860314 · Cited by 30
Body mass index and the risk of progression of chronic kidney disease.
Khedr, A., Khedr, E., & House, A. (2011) · Journal of renal nutrition · doi:10.1053/j.jrn.2010.12.001 · Cited by 30
Targher, G., Chonchol, M., Pichiri, I., & Zoppini, G. (2011) · Journal of Endocrinological Investigation · doi:10.3275/7614 · Cited by 30
Asao, T., Oki, K., Yoneda, M., Tanaka, J., & Kohno, N. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0360 · Cited by 32
Chen, C.-H., Wang, C.-K., Wang, C.-Y., Chang, C.-F., & Chu, T.-W. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i29.7004 · Cited by 29
“High blood pressure is a well-known independent risk factor for decreased renal function[47-49].”
Kaneyama, A., Hirata, A., Hirata, T., Imai, Y., Kuwabara, K., Funamoto, M., Sugiyama, D., & Okamura, T. (2022) · Hypertension Research · doi:10.1038/s41440-022-01041-9 · Cited by 35
Kawamoto, R., Akase, T., Ninomiya, D., Kumagi, T., & Kikuchi, A. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02320-0 · Cited by 29
Guo, V., Brage, S., Ekelund, U., Griffin, S., Simmons, R., Amin, R., Baker, G., Betts, M., Dickinson, A., Tcheugui, J. E., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12886 · Cited by 29
CKD in the Elderly: Kidney Senescence or Blood Pressure–Related Nephropathy?
Minutolo, R., Borrelli, S., & Nicola, L. D. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.004 · Cited by 29
The effects of weight change on glomerular filtration rate.
Chang, A. R., Greene, T., Wang, X., Kendrick, C. A., Kramer, H., Wright, J. T., Astor, B., Shafi, T., Toto, R., Lewis, J., et al. (2015) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfv219 · Cited by 29
Tavira, B., Coto, E., Gómez, J., Tranche, S., Miguélez, K., Ortega, F., Diez, B., Sánchez, E., Marín, R., Arenas, J., et al. (2013) · Gene · doi:10.1016/j.gene.2013.02.024 · Cited by 29
A simple prediction score for kidney disease in the Korean population
Kwon, K. S., Bang, H., Bomback, A. S., Koh, D. H., YUM, J., Lee, J. H., Lee, S., Park, S. K., Yoo, K., Park, S. K., et al. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01552.x · Cited by 28
Non-Dipper Status and Left Ventricular Hypertrophy as Predictors of Incident Chronic Kidney Disease
An, H., Park, S., Yoo, T., Kang, S.-W., Ryu, J., Lee, Y., Yu, M.-N., Ryu, D.-R., Kim, S., Kang, D.-H., et al. (2011) · Journal of Korean medical science · doi:10.3346/jkms.2011.26.9.1185 · Cited by 29
“In contrast to previous results (3), age, BMI, smoking, and eGFR were not significant predictors of incident CKD in the present study.”
BackgroundResultJun, M., Lv, J., Perkovic, V., & Jardine, M. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311401775 · Cited by 33
“CKD patients have higher rates of the general risk factors for cardiovascular disease, including hypertension, diabetes, obesity, and lipid abnormalities [Abboud et al. 2010; Rucker et al. 2009; Vaziri, 2006; Fox et al. 2004; Tozawa et al. 2002; Muntner et al. 2000; Manttari et al. 1995].”
BackgroundDisorders of Lipid Metabolism and Chronic Kidney Disease in the Elderly
Choudhury, D., Tuncel, M., & Levi, M. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.07.006 · Cited by 36
Obesity and insulin resistance as risk factors for chronic kidney disease.
Whaley-Connell, A., Pavey, B. S., Afroze, A., & Bakris, G. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05631.x · Cited by 29
Podocyte density as a predictor of long-term kidney outcome in obesity-related glomerulopathy.
Haruhara, K., Okabayashi, Y., Sasaki, T., Kubo, E., D'Agati, V., Bertram, J. F., Tsuboi, N., & Yokoo, T. (2024) · Kidney International · doi:10.1016/j.kint.2024.05.025 · Cited by 28
The Renal Pathology of Obesity: Structure-Function Correlations
Tsuboi, N., & Okabayashi, Y. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.002 · Cited by 34
Investigating associated factors with glomerular filtration rate: structural equation modeling
Jamshidi, P., Najafi, F., Mostafaei, S., Shakiba, E., Pasdar, Y., Hamzeh, B., & Moradinazar, M. (2019) · BMC Nephrology · doi:10.1186/s12882-020-1686-2 · Cited by 28
Tsai, C.-W., Huang, H.-C., Chiang, H.-Y., Chung, C.-W., Chang, S.-N., Chu, P.-L., & Kuo, C.-C. (2019) · Journal of Lipid Research · doi:10.1194/jlr.p084590 · Cited by 28
Kubo, S., Kitamura, A., Imano, H., Cui, R., Yamagishi, K., Umesawa, M., Muraki, I., Kiyama, M., Okada, T., & Iso, H. (2016) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.33530 · Cited by 28
Glomerulopathy Associated With Moderate Obesity
Okabayashi, Y., Tsuboi, N., Sasaki, T., Haruhara, K., Kanzaki, G., Koike, K., Miyazaki, Y., Kawamura, T., Ogura, M., & Yokoo, T. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.08.006 · Cited by 28
Shimizu, Y., Sato, S., Koyamatsu, J., Yamanashi, H., Nagayoshi, M., Kadota, K., & Maeda, T. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.035 · Cited by 23
Shastri, S., Katz, R., Shlipak, M. G., Kestenbaum, B. R., Peralta, C. A., Kramer, H., Jacobs, D. R., de Boer, I. H., Cushman, M., Siscovick, D. S., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.11.021 · Cited by 29
Percutaneous Radiofrequency Ablation Does Not Affect Glomerular Filtration Rate
Pettus, J., Werle, D. M., Saunders, W., Hemal, A., Kader, A., Childs, D. D., & Zagoria, R. (2010) · Journal of endourology · doi:10.1089/end.2010.0029 · Cited by 28
Childhood Obesity: Insight into Kidney Involvement
Carullo, N., Zicarelli, M., Michael, A., Faga, T., Battaglia, Y., Pisani, A., Perticone, M., Costa, D., Ielapi, N., Coppolino, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417400 · Cited by 33
“Research indicates that each unit increase in BMI heightens the risk of ESRD [20].”
Chen, H.-Y., Lu, F., Chang, C., Wang, R.-S., Yang, Y., Chang, Y., & Wu, J. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.029 · Cited by 26
Maeda, T., Yoshimura, C., Takahashi, K., Ito, K., Yasuno, T., Abe, Y., Masutani, K., Nakashima, H., Mukoubara, S., & Arima, H. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0198-7 · Cited by 27
Umesawa, M., Sairenchi, T., Haruyama, Y., Nagao, M., Yamagishi, K., Irie, F., Watanabe, H., Kobashi, G., Iso, H., & Ota, H. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.09.013 · Cited by 27
“In the current study, the association between diabetes mellitus and the risk for CKD was different from some prior studies (4, 10-12).”
BackgroundResultPaglialunga, S., Offman, E., Ichhpurani, N., Marbury, T., & Morimoto, B. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1274651 · Cited by 27
Kopf, S., Oikonomou, D., von Eynatten, M., Kieser, M., Zdunek, D., Hess, G., Morcos, M., Forsblom, C., Bierhaus, A., Groop, P., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0542-2 · Cited by 27
Progressive chronic kidney disease in primary care: modifiable risk factors and predictive model.
Herget-Rosenthal, S., Dehnen, D., Kribben, A., & Quellmann, T. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.06.010 · Cited by 27
Metabolic syndrome in children with chronic kidney disease and after renal transplantation
Litwin, M., & Niemirska, A. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2500-1 · Cited by 31
The Effect of Biliopancreatic Diversion Surgery on Renal Function—a Retrospective Study
Jose, B., Ford, S., Super, P., Thomas, G., Dasgupta, I., & Taheri, S. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0851-5 · Cited by 27
“Renal biopsy has shown that patients with a raised BMI are more likely to develop a specific pattern of kidney damage with glomerulomegaly and focal segmental glomerulosclerosis [12, 13].”
BackgroundInfluentialOdden, M. C., Tager, I. B., Gansevoort, R. T., Bakker, S. J. L., Fried, L. F., Newman, A. B., Katz, R., Satterfield, S., Harris, T. B., Sarnak, M. J., et al. (2013) · Annals of Epidemiology · doi:10.1016/j.annepidem.2012.12.004 · Cited by 26
Obesity in renal failure--health or disease?
Stolić, R. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.07.004 · Cited by 27
Independent influence of dietary protein on markers of kidney function and disease in obesity.
Friedman, A., Yu, Z., Juliar, B., Nguyen, J. T., Strother, M. R., Quinney, S., Li, L., Inman, M., Gomez, G., Shihabi, Z., et al. (2010) · Kidney International · doi:10.1038/ki.2010.184 · Cited by 27
Gosse, P., Coulon, P., Papaioannou, G., Litalien, J., & Lemétayer, P. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832a5ab3 · Cited by 27
What is the Optimal Fat Mass in Peritoneal Dialysis Patients?
Johnson, D. (2007) · Peritoneal Dialysis International · doi:10.1177/089686080702702s43 · Cited by 27
Prevalence of Impaired Kidney Function in Hospitalized Hypertensive Patients in Maiduguri, Nigeria
Nwankwo, E., Nwankwo, B., & Mubi, B. (2005) · doi:10.5580/1455 · Cited by 27
“A persistently elevated serum creatinine is a risk factor for chronic kidney disease (CKD) and an independent factor for progression of CKD to kidney failure (9).”
InfluentialDietary protein safety and resistance exercise: what do we really know?
Lowery, L. M., & Devia, L. (2009) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-6-3 · Cited by 26
Epidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26
“Obesity is an independent risk factor for the development and progression of chronic kidney disease.(204) Intentional weight loss in obese subjects (by lifestyle interventions, antiobesity agents, or weight loss surgery) with altered glomerular filtration rate or proteinuria improves proteinuria, albuminuria, and norm…”
BackgroundIqbal, J., Wu, H.-X., Nawaz, M., Jiang, H.-L., Xu, S.-N., Huang, B.-L., Li, L., Cai, J.-M., & Zhou, H.-D. (2023) · Obesity Reviews · doi:10.1111/obr.13656 · Cited by 26
Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease
Bullen, A., Katz, R., Kumar, U., Gutiérrez, O. M., Sarnak, M., Kramer, H., Shlipak, M., H., J., Judd, S., Cushman, M., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-022-03026-9 · Cited by 26
“Introduction Obesity is associated with incident hypertension, diabetes, cardiovascular disease (CVD), and kidney disease [1, 2].”
BackgroundGao, J.-L., Wang, A.-T., Li, X., Li, J.-J., Zhao, H.-L., Zhang, J., Liang, J.-T., Chen, S.-H., & Wu, S.-L. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000504251 · Cited by 26
Zhang, L., Zhang, M., Lv, Q., & Tong, N. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.047 · Cited by 27
A prospective cohort study of insomnia and chronic kidney disease in Japanese workers
Sasaki, S., Yoshioka, E., Saijo, Y., Bannai, A., Kita, T., Tamakoshi, A., & Kishi, R. (2017) · Sleep And Breathing · doi:10.1007/s11325-017-1508-3 · Cited by 28
Hayashi, K., Takayama, M., Abe, T., Kanda, T., Hirose, H., Shimizu-Hirota, R., Shiomi, E., Iwao, Y., & Itoh, H. (2017) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.38612 · Cited by 26
Hou, X.-G., Wang, C., Zhang, X.-P., Zhao, X., Wang, Y.-L., Li, C.-Q., Li, M., Wang, S., Yang, W.-F., Ma, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106778 · Cited by 26
“Even mild renal insufficiency increases the risk of cardiovascular events [5,6] and is predictive of the progression of kidney disease [7].”
BackgroundOh, S., Kim, S., Na, K., Kim, K. W., Chae, D., & Chin, H. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094120 · Cited by 26
“73 m(2) was the most important risk factor of renal progression, as observed in other studies [8,28].”
ResultJi, B., Zhang, S.-H., Gong, L.-L., Wang, Z.-H., Ren, W., Li, Q.-F., & Li, R. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.011 · Cited by 26
Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Khoshdel, A., Carney, S. L., & Gillies, A. H. B. (2012) · Current Cardiology Reviews · doi:10.2174/157340312801215773 · Cited by 24
“patients with chronic renal disease, hypertension and diabetes[14, 47-49].”
BackgroundAndo, M., Yanagisawa, N., Ajisawa, A., Tsuchiya, K., & Nitta, K. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr129 · Cited by 26
Ruan, L., Chen, W., Srinivasan, S., Xu, J.-H., Toprak, A., & Berenson, G. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9340-0 · Cited by 26
“Of interest, in this study cohort measures of obesity, hypertension, dyslipidemia and insulin resistance, which were found to be associated adversely with eGFR in previous studies [13, 33, 34], did not show any such independent adverse relationships.”
BackgroundResultHigashiyama, A., Okamura, T., Watanabe, M., Murakami, Y., Otsuki, H., Adachi, N., Kaneko, C., Uehara, E., Okayama, A., & Ueshima, H. (2009) · Hypertension Research · doi:10.1038/hr.2009.51 · Cited by 26
Kidney function decline and physical function in women
Lin, J., & Curhan, G. C. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn121 · Cited by 22
“We adjusted for several independent predictors of CKD identified in population-based studies including diabetes [2,28], hypertension [2,28], higher BMI [28,29] and cigarette smoking [28], which were also inversely associated with PFS in our cohort.”
Method
Metadata
- Authors
- Fox, C. S.
- Affiliations
- Framingham Heart Study (US)
- Corresponding author
- Fox, Caroline S.
- ORCID
- Fox, Caroline S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-02-18
- Volume
- 291
- Issue
- 7
- Pages
- 844
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1992283514
- Cited by
- 1,241
- References
- 0
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 50 · 2023: 37 · 2022: 53 · 2021: 62 · 2020: 62 · 2019: 47 · 2018: 49 · 2017: 59 · 2016: 81 · 2015: 49 · 2014: 79 · 2013: 83 · 2012: 68
- FWCI
- 28.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (N01‐HC25195)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- chronic kidney disease, risk factors, glomerular filtration rate, diabetes mellitus, smoking, body mass index, age, MDRD equation, cardiovascular disease, end-stage renal disease, community-based cohort, risk prediction model, renal function decline, hyperlipidemia, antihypertensive drugs, antihypertensive medication adherence
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Longitudinal Studies, Male, Middle Aged, Risk Factors, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
